FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...